Cover image of the article: Drug-Related Mutational Patterns in Hepatitis B Virus (HBV) Reverse Transcriptase Proteins From Iranian Treatment-Naïve Chronic HBV Patients

Image Credit:Hepat Mon

Drug-Related Mutational Patterns in Hepatitis B Virus (HBV) Reverse Transcriptase Proteins From Iranian Treatment-Naïve Chronic HBV Patients

Authors

Mostafa Mahabadi1, Mehdi Norouzi1, Seyed Moayed Alavian2, katayoun samimirad3, Talat Mokhtari Azad1, Esmaeil Saberfar4, Mahmood Mahmoodi5, fatemeh ramezani1, Hadi Karimzadeh1, Reza Malekzadeh6, G montazeri6, Azim Nejatizadeh7, Masood Ziaee8, Farshid Abedi9, behrooz ataei10, Majid Yaran10, Babak Sayad11, Mohammad Somi12, Gholamreza Sarizadeh13, Ismaeil Sanei-Moghaddam14, Fariborz Mansour-Ghanaei15, Houshang Rafatpanah16, Mohammad Amin Pourhosseingholi17, Hossein Keyvani18, Ebrahim Kalantari19, Mehdi Saberifiroozi20, Mohammad Ali Judaki1, Shiva Ghamari1, Maryam Daram1, Zeinab Fazeli1, Zahra Goodarzi4, Abulfazl Khedive1, Abdolvahab Moradi21, Seyed Mohammad Jazayeri1,*
1Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
2Middle East Liver Diseases Center (MELD Centers), Tehran, IR Iran
3Hepatitis C Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
4The research and development department of Bayerpaul vaccine and pharmaceutical company, Tehran, IR Iran
5Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
6Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
7Research Center for Molecular Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
8Hepatitis Research Center , Department of Internal Medicine, Faculty of medicine, Birjand University of Medical Sciences, Birjand, IR Iran
9Department of Infectious Disease, Mashhad University of Medical Sciences, Mashhad, IR Iran
10Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
11Kermanshah Liver Diseases and Hepatitis Research Center, Kermanshah, IR Iran
12Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
13Educational Region of Khouzestan Blood Transfusion Organization, Ahvaz, IR Iran
14Department of Gastroenterology, Zahedan University of Medical Sciences, Zahedan, IR Iran
15Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, IR Iran
16Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran
17Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
18Department of Virology, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
19Gholhack Medical Laboratory, Tehran, IR Iran
20Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
21Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, IR Iran
*Corresponding Author: Hepatitis B Lab, Department of Virology, School of Public Health, Tehran University of Medical Sciences, P.O. Box: 14155-6446, Tehran, IR Iran. Tel.: +98-2188962343, Fax: +98-2188992660, E-mail: jazayerism@tums.ac.ir. Email: jazayerism@tums.ac.ir

Hepatitis Monthly:Vol. 13, issue 1; e93042
Published online:Jan 20, 2013
Article type:Research Article
Received:May 06, 2019
Accepted:Nov 12, 2012
How to Cite:Mahabadi M, Norouzi M, Alavian SM, samimirad K, Mokhtari Azad T, et al. Drug-Related Mutational Patterns in Hepatitis B Virus (HBV) Reverse Transcriptase Proteins From Iranian Treatment-Naïve Chronic HBV Patients. Hepat Mon. 2013;13(1):e93042. doi: https://doi.org/10.5812/hepatmon.6712

Abstract

Background: Immunomodulators and Nucleotide analogues have been used globally for the dealing of chronic hepatitis B virus (HBV) infection. However, the development of drug resistance is a major limitation to their long-term effectiveness.

Objectives: The aim of this study was to characterize the hepatitis B virus reverse transcriptase (RT) protein variations among Iranian chronic HBV carriers who did not receive any antiviral treatments.

Materials and Methods: Hepatitis B virus partial RT genes from 325 chronic in active carrier patients were amplified and directly sequenced. Nucleotide/amino acid substitutions were identified compared to the sequences obtained from the database.

Results: All strains belonging to genotype D.365 amino-acid substitutions were found. Mutations related to lamivudine, adefovir, telbivudine, and entecavir occurred in (YMDD) 4% (n = 13), (SVQ) 17.23% (n = 56), (M204I/V + L180M) 2.45% (n = 8) and (M204I) 2.76% (n = 9) of patients, respectively.

Conclusions: RT mutants do occur naturally and could be found in HBV carriers who have never received antiviral therapy. However, mutations related to drug resistance in Iranian treatment-naïve chronic HBV patients were found to be higher than other studies published formerly. Chronic HBV patients should be monitored closely prior the commencement of therapy to achieve the best regimen option.

Highlights

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Jan
2018
Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey

Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey

Ali Asan,
Murat Sayan,
Sila Akhan,
Suda Tekin Koruk,
Bilgehan Aygen,
Fatma Sirmatel
,et al.

Asan A, Sayan M, Akhan S, Tekin Koruk S, Aygen B, et al. Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey. Hepat Mon. 2018;18(1):e12472. doi: https://doi.org/10.5812/hepatmon.12472

1
Oct
2013
Substitution Rtq267h of Hepatitis B Virus Increases the Weight of Replication and Lamivudine Resistance

Substitution Rtq267h of Hepatitis B Virus Increases the Weight of Replication and Lamivudine Resistance

Bo Qin,
Bo Zhang,
Xiaodong Zhang,
Tingting He,
Wenying Xu,
Lijun Fu
,et al.

Qin B, Zhang B, Zhang X, He T, Xu W, et al. Substitution Rtq267h of Hepatitis B Virus Increases the Weight of Replication and Lamivudine Resistance. Hepat Mon. 2013;13(10):e12160. doi: https://doi.org/10.5812/hepatmon.12160

1
Oct
2013
The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment

The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment

Sepide Ezzatpanah Fard,
Zohreh Sharifi,
Seyed Masoud Hosseini,
Mahmood Mahmoodian Shooshtari

Ezzatpanah Fard S, Sharifi Z, Hosseini SM, Mahmoodian Shooshtari M. The incidence of Drug- Resistant Mutants in Patients With Chronic HBV Infection After Lamivudine Treatment. Jundishapur J Microbiol. 2013;6(8):e7366. doi: https://doi.org/10.5812/jjm.7366

1
Apr
2014
Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

Ali Karimi,
Loghman Salimzadeh,
Nader Bagheri

Karimi A, Salimzadeh L, Bagheri N. Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran. Jundishapur J Microbiol. 2014;7(4):e10196. doi: https://doi.org/10.5812/jjm.10196

12
Sep
2015
Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features

Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features

Vahdat Poortahmasebi,
Reza Malekzadeh,
Ghodratollah Montazeri,
Ehsan Fakhari,
Mehdi Norouzi,
Azam Khamseh
,et al.

Poortahmasebi V, Malekzadeh R, Montazeri G, Fakhari E, Norouzi M, et al. Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features. Jundishapur J Microbiol. 2015;8(9):e20262. doi: https://doi.org/10.5812/jjm.20262

More by these authors

Mostafa MahabadiPubMedScholar
Mehdi NorouziPubMedScholar
Seyed Moayed AlavianPubMedScholar
katayoun samimiradPubMedScholar
Talat Mokhtari AzadPubMedScholar
Esmaeil SaberfarPubMedScholar
Mahmood MahmoodiPubMedScholar
fatemeh ramezaniPubMedScholar
Hadi KarimzadehPubMedScholar
Reza MalekzadehPubMedScholar
G montazeriPubMedScholar
Azim NejatizadehPubMedScholar
Masood ZiaeePubMedScholar
Farshid AbediPubMedScholar
behrooz ataeiPubMedScholar
Majid YaranPubMedScholar
Babak SayadPubMedScholar
Mohammad SomiPubMedScholar
Gholamreza SarizadehPubMedScholar
Ismaeil Sanei-MoghaddamPubMedScholar
Fariborz Mansour-GhanaeiPubMedScholar
Houshang RafatpanahPubMedScholar
Mohammad Amin PourhosseingholiPubMedScholar
Hossein KeyvaniPubMedScholar
Ebrahim KalantariPubMedScholar
Mehdi SaberifirooziPubMedScholar
Mohammad Ali JudakiPubMedScholar
Shiva GhamariPubMedScholar
Maryam DaramPubMedScholar
Zeinab FazeliPubMedScholar
Zahra GoodarziPubMedScholar
Abulfazl KhedivePubMedScholar
Abdolvahab MoradiPubMedScholar
Seyed Mohammad JazayeriPubMedScholar
Share
Cited by
Metrics